Design, synthesis and structure relationships of new N,N',N'',N'''-tetrakis (ω-amino alkyl) tetraazamacrocycles

Antiviral Chemistry and Chemotherapy

Volumn 9, Issue 1, 1998, Pages 73-84

  Trabaud, C ^a,b   Dessolin, J ^a,b   Camplo, M ^a,b   Hantz, O ^b   Zoulim, F ^b   Borel, C ^b   Meyer, M ^a   Pepe, G ^a   Chermann, J C ^b   Kraus, J L ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSERM   (France)

Author keywords

Molecular modelling; Structure activity; Synthesis; Tetraazamacrocycles

Indexed keywords

AMINO ACID MIXTURE; ANTIVIRUS AGENT; MACROCYCLIC COMPOUND; METAL; TETRAAZAMACROCYCLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; DUCK; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; AZA COMPOUNDS; CELL LINE; CELLS, CULTURED; DNA, VIRAL; DRUG DESIGN; DUCKS; HEPATITIS B VIRUS, DUCK; HIV-1; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS REPLICATION;

EID: 0031985767     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Asato E, Ozutsumi K, Ishiguro S, Kida S & Murase I (1990) Unusual affinities of monovalent anions to dicopper (II), complexes with N,N′,N″,N‴-tetrakis[2-aminoethyl]-tetra-azacycloalkanes. Inorganica Chimica Acta 167:189-193.
2. Bergeron R, McManis J, Weimar W, Shreier K, Gao F, Wu G, Ortiz-Ocasio J, Luchetta G, Porter C & Vinson T (1995) The role of charged polyamine analogue recognition. Journal of Medicinal Chemistry 38:2278-2285.
3. Bridger G, Skerlj R, Thornton D, Padmanabhan S, Martellucci S, Henson G, Abrams M, Yamamoto N, De Vreese K, Pauwels R & De Clercq E (1995) Synthesis and structure-activity relationships of phenylenebis(methylene) linked bis-tetraazamacrocycles that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker. Journal of Medicinal Chemistry 38:366-378.
4. Bridger G, Skerlj R, Padmanabhan S, Martellucci S, Henson G, Abrams M, Joao HC Witvrouw M, De Vreese K, Pauwels R & De Clercq E. (1996) Synthesis and structure-activity relationships of phenylene bis (methylene) linked bis-tetraazamacrocycles that inhibit human immunodeficiency virus replication. 2. Effect of heteroaromatic linkers on the activity of biscyclams. Journal of Medicinal Chemistry 39:109-119.
5. Buttafava A, Fabbrizzi I, Perotti A, Poggi A, Poll G & Seghi B (1986) Trivalent nickel bis (triaza macrocyclic) complexes. Ligand ring size and medium effects on the nickel (III)/nickel (II) redox couple potential. Inorganic Chemistry 25:1456-1461.
6. Cavelier-Frontin F, Pèpe G, Verducci J, Siri D & Jacquier R (1992) Prediction of the best linear precursor in the synthesis of cyclotetrapeptides by molecular mechanic calculations. Journal of the American Chemical Society 114:8885-8890.
7. De Clercq E (1995) Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections. Journal of Medicinal Chemistry 38:2491-2517.
8. De Clercq E, Yamamoto N, Pauwels R, Baba M, Schols D, Nakashima H, Balzarini J, Debyser Z, Murrer BA, Scharwtz D, Thornton D, Bridger G, Fricker S, Henson G, Abrams M & Picker D (1992) Potent selective inhibition of human immunodeficiency virus HIV-1 and HIV-2 replication by a class of biscyclams interacting with a viral uncoating event. Proceedings of the National Academy of Sciences, USA 89:5286-5290.
9. De Clercq E, Yamamoto N, Pauwels R, Balzarini J, Witvrouw M, De Vreese K, Debyser, Z, Rosenwirth B, Peichl P, Datema R, Thornton D, Skerlj R, Gaul F, Padmanabhan S, Bridger G, Henson G & Abrams M (1994) Highly potent and selective inhibition of human immunodeficiency virus by the biscyclam derivative JM3100. Antimicrobial Agents and Chemotherapy 38:668-674.
10. Fourel I, Gripon P, Hantz O, Cova L, Lambert I, Jacquet C, Watanabe K, Fox J, Guillozo C & Trepo C (1989) Prolonged duck hepatitis B virus replication in duck hepatocytes cocultivated with rat epithelial cells: a useful system for antiviral testing. Hepatology 10:186-191.
11. Haertle T, Carrerra C, Wasson B, Sowers L, Richman D & Carson D (1988) Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2′,3′-dideoxyadenosine derivatives. Journal of Biological Chemistry 263:5870-5875.
12. Joao HC, De Vreese K, Pauwels R, De Clercq E, Henson G & Bridger G (1995) Quantitative structural activity relationship study of bis-tetraazacyclic compounds. A novel series of HIV-1 and HIV-2 inhibitors. Journal of Medicinal Chemistry 38:3865-3873.
13. 1H NMR. EMBO Journal 11:3059-3065.
14. Pèpe G & Siri D (1990) GenMol. A fast program for molecular modeling: application to the determination of pscychotonic or sedative effect of tricyclic drugs. In Modeling of Molecular Structure and Properties, pp. 93-101. Edited by JL Rivail. Amsterdam: Elsevier Science.
15. Pèpe G, Meyer M, Faury P, Graciet JC, Chermann JC & Kraus JL (1996) A model allowing the design of modified nucleosides as HIV-RT inhibitors. European Journal of Medicinal Chemistry 31:775-786.
16. Pugh J & Summers J (1989) Infection and uptake of duck hepatitis B virus by duck hepatocytes maintained in the presence of dimethyl sulfoxide. Virology 172:564-572.
17. Rey F, Barré-Sinoussi F, Schmidtmayerova H & Chermann JC (1987) Detection and titration of neutralizing antibodies to HIV using an inhibition of the cytopathic effect of the virus on MT-4 cells. Journal of Virological Methods 16:239-249.
18. + cells by selected HIV strains is not inhibited by anti-CD4 monoclonal antibodies. Journal of Virological Methods 181:165-171.
19. Rossmann MG (1988) Antiviral agents targeted to interact with viral capsid proteins and a possible application to human immunodeficiency virus. Proceeding of the National Academy of Sciences, USA 85:4625-4627.
20. Sells M, Chen L & Acs G (1987) Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proceedings of the National Academy of Sciences, USA 84:1005-1009.
21. 3 together with formation constant determinations and pKa measurements for the aquated bimetallic species. Journal of the Chemical Society Dalton Transactions 2921-2928.
22. Turin F, Borel C, Benchaid M, Jamard C, Guguen-Guillouzo C, Trepo C & Hantz O (1996) n-butyrate, a cell cycle bloker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes. Journal of Virology 70:2691-2696.